Quick Takeaways
- Gino Santini has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,534,726.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Gino Santini and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| COLL | COLLEGIUM PHARMACEUTICAL, INC | Director | $3,534,726 | -$201,018 | -5.4% | 15 Aug 2025 |
| ALNAQ | Allena Pharmaceuticals, Inc. | Director | 03 Jun 2021 | |||
| CMPS | COMPASS Pathways plc | Director | 12 Jun 2025 | |||
| HZNP | Horizon Therapeutics Public Ltd Co | Director | 06 Oct 2023 | |||
| ICPT | INTERCEPT PHARMACEUTICALS, INC. | Director | 08 Nov 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|